The human ocular surface
Structure and function
The human eye is a highly specialized photoreceptive organ through which exquisite vision is maintained and coordinated by its internal structures. A healthy ocular surface is critical for proper vision. This barrier spans the cornea at its most central aspect and is continuous with the adjacent conjunctiva which reflects over the globe and terminates at the mucocutaneous junction of the lash line. The cornea, our window to the world, forms the outer most central region of the ocular surface ( Fig. 1 ) and provides two-thirds of the eye's refractive power. In addition to playing a central role in vision perception, it also serves a protective role by providing the first line of defense against injury, infection and desiccation. Three cellular layers comprise the cornea (Fig. 1A) , each separated by a basement membrane (BM). The anterior human cornea makes up 10% of the total thickness and is composed of a 5-7 layered, non-keratinized, stratified squamous epithelium. This layer is segregated from the underlying transparent, yet dense keratocyte (fibrocyte)-containing, collagenous, avascular stroma (comprising 90% of the corneal volume) by Bowman's layer. This BM-like structure is predominantly found in humans and is thought to absorb ultraviolet radiation. 1 The corneal stroma is partitioned from a monolayer of endothelial cells by Descemet's membrane (Fig. 1A) , a substrate for these specialized cells whose main function is to transport nutrients and water to and from the stroma to prevent corneal oedema and maintain optimal hydration. 2 In contrast, the conjunctiva, the loose tissue that drapes the opaque sclera, is vascularized and is divided into three zones (bulbar, forniceal and palpebral) between its origin on the sclera and the epidermis of the eyelids 3 (Fig. 1C) . The conjunctiva's most prominent functions are immune related, carried out by its resident antigen-presenting Langerhans cells, and secretory, facilitated by mucin-producing goblet cells. 4 
Anatomical development
The cornea is one of the last structures of the eye to form and its development involves the interaction of the lens vesicle with the overlying surface ectoderm. 5 Although the morphogenic programmes responsible for its development are incompletely characterized, murine and avian studies suggest that Pax6, the master gene for oculogenesis, 6 and genes involved in Wnt-signaling 7 pathways are critical. Embryologically, the corneal epithelium develops from surface ectoderm and is first apparent at 6 weeks post-ovulation. 8 Maturation of the corneal epithelium is related to eyelid development. 9 Rudimentary lids fuse 8 weeks after ovulation and do not separate until after 26 weeks. 9 A recent study by Rodrigues et al. 10 reported a single layer of cuboidal cells with an overlying 'periderm' at 8 weeks gestation (WG), a three-to-four layered epithelium at 12 -13 WG and a four-to-six layered epithelium by 36 WG. The underlying stroma and endothelium form from neural crest mesenchymal cells, which Duke-Elder and Cook 11 suggest, invade into the emerging space between the surface ectoderm and the regressing lens vesicle in two 'waves': the first wave forming the corneal endothelium and the second contributing to the corneal stroma. While some authors have advocated this invasion of mesenchymal cells from the periphery, 12 Sevel and Isaacs 9 dispute this, arguing the corneal stroma develops in situ from mesenchymal cells. In support of this, they cite the absence of more advanced mesenchymal cells in the central cornea, which would be expected if these cells led the invasion into the space. 9 They concluded that previous investigators have been misled by the compressive effects of the lens on the central cornea early on in development, which inhibits stromal development until it starts to recede. 9 
Stem cells of the cornea

Epithelial stem cells
The limbus is a narrow (1-2 mm) transitional zone that segregates the corneal from conjunctival epithelium (Fig. 1C) and is the residence for epithelial stem cells (SCs) that replenish aged corneal epithelial cells throughout life. 13 -15 The first indirect evidence of the presence of SCs in the limbus was by Mann 16 who observed the movement of pigmented basal cells from the limbus towards the wounded central cornea in rabbits. The notion that corneal epithelial stem cells (ESCs) arise solely from the limbal zone was recently challenged by studies in animals that revealed the central cornea possessed proliferative potential similar to limbal-derived cells. 17 ESCs are not evenly distributed throughout the limbus (hereby called LSC) but are more abundant in the superior and inferior, than in the nasal and temporal limbal zones 18 -20 (Fig. 1C) . Increased SC reserves in these regions cannot be accurately explained but may be due to the protection offered by the upper and lower eyelids. In situ, LSC are termed 'unipotent' as they only give rise to cells of a corneal lineage and are often identified in small clusters (Fig. 1B, inset) . 20, 21 Basal limbal epithelial cells are 10 mm in diameter, somewhat smaller than basal cells of the central cornea ( 17 mm). 22 Moreover, these smaller cells have a high proliferative capacity, are associated with markers of SC and retain DNA labels (e.g. tritiated thymadine or bromodeoxyuridine). 23 DNA-label retention is indicative of slow cycling cells and these assays have been used to predict that the number of SCs within the limbus can be as high as 10%. 24 LSCs undergo asymmetric division whereby one daughter is retained in the SC pool, while the other detaches from its BM and looses 'stemness' as it migrates upwards and across towards the central cornea (centripetal migration). This differentiated cell is now termed a transient amplifying cell (TAC) and it acquires a higher proliferative capacity. However, following multiple rounds of replication, it becomes a post-mitotic terminally differentiated cell that is sloughed from corneal surface. This cycle is continuously replayed throughout the lifespan of the organism at a rate that is dependent on the homeostatic or pathological state of the cornea. Moreover, the rate at which corneal epithelium is self-renewed can be explained by the X, Y, Z hypothesis which predicts that the balance between cell proliferation and cell loss is directed by the equation X þ Y ¼ Z, where X represents corneal basal cell movement towards the surface, Y represents movement of peripheral cells towards the central cornea and Z represents desquamation of the surface epithelium. 25 The corneal epithelium provides us with an ideal opportunity to study SCs and their differentiated progeny within the same microenvironment. Furthermore, the anatomical location of these cells makes them relatively easy to view using in vivo confocal and slit-lamp microscopy and access using minimally invasive techniques (e.g. superficial limbal biopsy), facilitating investigations into their functional significance and regulatory programmes. In addition to understanding the functions of the limbus and its SC reservoir through decades of research, this basic knowledge has provided a platform for the development of novel therapeutic strategies to treat patients with severe and persistent corneal epithelial defects that require corneal epithelial replacement due to LSC failure or deficiency (LSCD). LSCD is the term reserved for a heterogeneous group of diseases characterized by excessive damage to the limbus, which results in insufficient numbers of SC being available to replenish the continuously remodelling corneal epithelium (see Daniels review in this issue).
ESC niche
The SC niche hypothesis was first proposed by Schofield 26 who suggested that SCs are maintained in an undifferentiated state because of their exquisitely tuned microenvironment. The LSC niche has anatomical and functional dimensions. 27, 28 Anatomically, LSC reside within the palisades of Vogt, a location first proposed in 1971 13 and subsequently supported by in vivo evidence. 27, 29 This region is characterized by numerous undulations, with limbal papillae extending downward into the stroma (Fig. 1B) . It has been hypothesized that these invaginations allow basal limbal cells to interact with the underlying rich vascular network that provides nutrients, supportive factors such as soluble signals 30 and an increased surface area, allowing for a higher concentration of LSCs within a small area. 29 The deep limbal ridges also shelter SCs from trauma. Basal limbal epithelial cells within the palisades reside amongst melanocytes 31 and often present with a melanin cap (Fig. 1B, inset) an additional protective mechanism against environmental insults such as ultraviolet radiation. Further indication of the importance of the niche is evidence that the BM directly beneath LSCs is distinct from the matrix, which supports the corneal epithelium. 32 -34 More recently, two secondary niche-like structures were identified within the adult limbal zone. The first, termed 'limbal epithelial crypts', refer to limbal epithelial invaginations that radiate as 5-7 solid cords of cells either peripherally into conjunctival stroma or circumferentially into limbal stroma 27 and the second are 'focal stromal projections' which are finger-shaped projections of limbal stroma that penetrate through to the epithelium, surrounded by smaller, basal cells. 20 In the developing human eye, a ridge-like structure circumscribes the peripheral cornea and is thought to comprise the rudimentary LSC niche. This structure is identifiable as an elevation in the limbal zone that disappears just prior to eyelid opening and exposure to amniotic fluid. 21, 35 ESC markers A single definitive marker that identifies SC in any human organ continues to remain elusive. In general SCs are identifiable through morphological and functional characteristics (described above) and phenotypically using a panel of positive and negative signature genes under quiescent conditions. Some of the better accepted makers of LSC, include p63, 36 cytokeratin (CK)-15 37 and the ATP-binding cassette transporter protein ABCG2. 38 Negative markers include CK-3/-12.
10,14,39 p63 is a transcription factor that regulates cell proliferation during epithelial morphogenesis. 40 Of the six different isoforms of p63, the DNp63a species is deemed the most specific identification marker for LSC in the resting healthy limbus. 41 CK-15, an intermediate filament protein, is important in supporting the cell's cytoskeleton and was identified as one of the most highly and differentially expressed genes between central corneal and limbal epithelium.
37 ABCG2 is responsible for effluxing dyes such as Hoechst 33342 42 and is commonly observed in side population cells, which have phenotypic and functional features of SC. Watanabe et al. 38 also showed expression of ABCG2 by basal limbal epithelial cells and suggested that immunoreactive cells were putative SC. Cytokeratins CK-3/-12 are also important structural components of cells and are prominent differentiation markers expressed by central corneal epithelium but excluded from LSC. 10, 14, 39, 43 More recently Di Girolamo et al. 44 proposed that the low affinity nerve growth factor receptor p75, serves as an additional candidate LSC marker because of its expression pattern in regions of the ocular surface that harbour SC. It should be noted that many of the markers that identify SCs are also selective for early TAC, making isolation of a pure SC population near impossible.
Stromal stem cells
Although the majority of research to date has focused on LSCs, recent investigations have sought to determine what factors regulate and renew the corneal stroma as it has been proposed that this intermediate layer may also contain an adult SC population. 45 Indeed, identification and isolation of such cells might be a valuable resource for bioengineering corneal stroma or for cell-based therapies 45 particularly for patients with corneal scarring. Certainly, treating mice with human adult mesenchymal SCs, isolated from the corneal stroma, restored corneal transparency 46 and mesenchymal SC culture medium has been shown to modulate wound healing activities of human corneal stromal fibroblasts in vitro, implying that factors within this supernatant could be isolated for future therapeutic use. 47 Mesenchymal SCs found within the corneal stroma are probably neural crest derived. One study isolated CD133 þ monocytic progenitors from the human corneal stroma and differentiated them into fibroblast-like cells, suggesting the potential of these cells for corneal stromal restoration. 48 
Endothelial stem cells
After birth, there is little or no proliferation of the corneal endothelium, leading to irreversible corneal oedema when this cellular layer is depleted or damaged. 49 Further, adult endothelial cells are difficult to culture using standard tissue culture techniques. 50 Interestingly, cells from younger donors, including neonatal eyes, are easier to grow. 50, 51 It would be of value however to establish whether foetal endothelial cells can be cultured and, if cells with stem-like characteristics can be isolated from this source, to determine their utility for treating endothelial dysfunction. Recent studies have reported the ability to culture human corneal endothelial cells that demonstrate stem-like properties. 52 Adult human corneal endothelial cells are typically growth arrested in the G1 cell cycle. When specific inhibitors of Rho and Rho-associated kinases (ROCKs) are used, cell proliferation and adhesion is re-ignited and apoptosis is suppressed. 53 However, the consequences of such ex vivo manipulation for transplanted human endothelial cells are yet to be appreciated.
Alternative cells for corneal epithelial repair
Conjunctival epithelium
Current demand for human corneal cells and tissue for ocular surface reconstruction and transplantation far outweighs supply, and this is one reason for identifying an alternative cellular source. The other major reason is to treat patients with bilateral disease with an autologous source of cells, to avoid immunosuppression and reduce the risk of rejection. Non-ocular cells for ocular surface rehabilitation in patients suffering LSCD have been explored and will be discussed below. However, an obvious cell type, anatomically adjacent to the cornea, harbouring its own SC population, abate in a less well-defined niche 54 is the conjunctival epithelium and while cells of corneal and conjunctival lineages are typically segregated, corneal epithelial-like cell clusters have been found within the conjunctiva. 54 , 55 Kurpakus et al. 55 showed that bovine conjunctival epithelial cells cultured on a corneal BM eventually expressed corneal-specific keratins and Tanioka et al. 56 identified corneal CK-3/12 expression in human conjunctival epithelial cells engrafted in rabbits. These observations support the notion that human conjunctival and limbal epithelia may be interchangeable. Indeed, stromal signals that cells encounter upon transplantation are thought to dictate their fate 57 and this could explain the successful reconstitution and maintenance of a healthy cornea in patients and experimental animals with LSCD transplanted with conjunctival epithelial progenitors. 56, 58, 59 However, after severe limbal damage, the conjunctiva is unable to reconstitute the corneal surface in situ with normal cells. Instead an opaque, inflamed and highly vascularized conjunctival pannus resurfaces the cornea, 60 probably due to persistent inflammatory signals which emanate from the local microenvironment.
Oral mucosal epithelium
Oral mucosal SCs are also located in the basal layer of this specialized epithelia, 61 are identified with LSC markers including, p75, 62 CK-15 63 and DNp63a 64 and possess the ability to be reprogrammed into corneal epithelial-like cells. 62 This can be achieved after seeding cells onto human amniotic membrane (HAM) and placing this bio-construct over the cornea. Oral mucosal epithelial cells have the capacity to engraft onto the ocular surface and survive after transplantation in patients with LSCD following alkali injures. 63 However, these cells have not provided satisfactory longterm results as have autologous limbal-derived cells, possibly because a significant proportion are not able to differentiate into cytokeratin 12-expressing corneal epithelium. 63 
Cutaneous epithelium
SCs of the epidermis are thought to reside in a primary niche within the hair follicle bulge and in secondary zones between the rete ridges of the epidermis. This latter repository is remarkably similar to that of the cornea as it offers protection from trauma and provides nutrition from the adjacent vasculature to ensure 'stemness' is maintained. 65 Hair follicle SCs too can be identified with LSC markers including CK-15 and p63 66 and have the plasticity to differentiate into corneal epithelial cells if provided with an appropriate limbal microenvironment. 66, 67 In a goat model of LSCD, it was recently demonstrated that 80% of damaged corneas could be reconstituted with autologous epidermal-derived somatic SCs. 68 Baring any adverse side-effects, translation of these results into humans would have immense global implications, as autologous skin is more abundant than limbus and would reduce risk of developing ocular complications from harvesting large or multiple limbal biopsies. Interestingly, the converse has also been achieved, where corneal epithelium was reprogrammed into epidermis through a multistep process that involved dermal (stromal) developmental cues. 69 It should be highlighted however, that in ex vivo human tissue recombination models, cutaneous epithelial cells seeded on a corneal stroma (or visa versa) formed a corneal-like structure. However, histological features and more importantly functional properties including transparency could not be effectively achieved. 70 
Corneal stem cells
British Medical Bulletin 2011
Notably, such studies were performed without a SC population and were performed in a system that lacked the complex interactions of a living organ.
The limbus and cornea express a complex and differential pattern of neurotrophic factors and corresponding receptors which are thought to govern SC activity and phenotype. 71 Curiously, once removed from their in situ niche, human LSC can be programmed to display functional neuronal properties and may therefore be a potential autologous source of neurons to treat photoreceptor degeneration including age-related macular degeneration and retinitis pigmentosa. 72 
Mesenchymal stem cells
Mesenchymal SC can be isolated from bone marrow and are multipotent 73 with the capacity to differentiate into airway epithelium. 74 These cells have been successfully administered to repair the corneal epithelium in alkali burnt rabbits 75 and rats. 76 Gomes et al. 77 recently isolated immature dental pulp SCs from human deciduous teeth and subsequently engineered and transplanted sheets of these cells to reconstruct denuded corneas. These cells co-expressed mesenchymal and embryonic SC markers and were capable of differentiating into cells of the three embryonic layers. 78 
Embryonic and fetal stem cells
Embryonic SCs derived from the inner cell mass of a blastocyst are pluripotent and have been successfully implanted to reconstruct chemically damaged mouse corneas. 79 When nurtured on a microenvironment that simulates the limbal niche, they express corneal-specific antigens. 80 Curiously, the embryonic SC transcription factor (OCT4), which is normally switched off in all differentiated somatic cells, was found in basal limbal epithelium of human corneas. 81 Inducing all embryonic SCs within a given culture to acquire a corneal epithelial phenotype has been problematic. However, it was noted that adhesion to collagen type IV partially induced cell differentiation. Therefore, to obtain an enriched population of corneal epithelial cells, the oculogenic transcription factor pax6 was introduced into monkey embryonic SCs and transfected cells were cultured on a collagen IV matrix. Despite successfully colonizing wounded murine corneas with formation of multiple cellular layers, only 30% of the cells acquired a corneal phenotype. 82 Other major hurdles associated with the use of genetically manipulated embryonic SCs as a therapy include the risk of contaminating the host with other germ cell, the potential to develop teratomas 83 and the long-term stability of the transgene either in culture or in situ.
Although the literature on human foetal corneal SCs is limited, our group has recently demonstrated their cultivatibility and remarkable resemblance in terms of morphology and phenotype to their adult counterparts. Foetal corneal SC cultures may offer considerable promise as a transplantable source; however, significant ethical and legal hurdles need to be overcome, before their inclusion as a potential alternative cellular source to treat LSCD. Foetal SCs of the human skin have been better characterized compared with their ocular equivalents. Given these two tissue share many properties, it is likely that their SC populations have similar phenotypic and functional characteristics as has been demonstrated in adult tissue. 36, 84 Notably, foetal skin has been shown to possess unique wound healing properties; foetal skin in utero is observed to have rapid and scarless tissue repair. 85 Wound healing studies in the foetal cornea are lacking, but may yield similar findings, with the potential to develop new therapeutic strategies for diseases of the adult cornea.
Discussion and concluding remarks
Identification of multiple SC sources has inspired a surge of research, which takes advantage of their plasticity. However, it is important to realize that several basic scientific criteria must be met before SCs can be used to treat disease. These include their identification, accessibility and extraction, expansion on an appropriate substrate, assurance that cell manipulation and reprogramming is reliable and safe and an optimal delivery system for integration into the host devised.
One major challenge for corneal replacement therapy has been in engineering a biocompatible tissue equivalent. Indeed, functional corneas have been constructed from layers immortalized cell lines 86 and from utilizing acellular porcine corneas as the starting scaffold, infusing this matrix with each of the three cell types that make up the native cornea, and successfully transplanting the bio-construct into recipient animals. 87 In SC-targeted replacement therapy, for example, expanding LSCs for the purpose of treating patients with LSCD, a suitable culture environment is required as well as a biocompatible scaffold to promote propagation and an appropriate transportation medium. Gold-standard vehicles used to support LSCs include HAM 88 -90 and fibrin. 91 To date, hundreds of patients have received either with approximately equal success rates ( 80%). 91, 92 Rama's et al. 92 results are particularly impressive as his group assessed over 100 patients with the same cause (burn-dependent) of LSCD and up to 10-year follow-up. Moreover, they noted that cultures of autologous LSC in which p63-bright cells comprised .3% of the total number of clonogenic cells were associated with successful transplantation in 78% of patients. 92 Despite the significant advances in corneal bioengineering and corneal SC therapy, most, if not all investigational protocols rely on the use of animal products and/or allogeneic human cells and tissue. The fundamental principles for current ocular surface reconstruction therapy with SCs for patients with LSCD are drawn from Rheinwald and Green's pioneering work 93 who were first to culture human skin keratinocytes on a layer of murine feeder 3T3 embryonic fibroblasts. These cells were found to maintain human epithelial SC colonies implying the potential for this co-culture model for skin reconstruction. In the past 30 years since this technique became widely used, few adverse side effects have been recorded. However, it is important to note that 3T3 cells are a potential source of xenoantigenicity 94 and viral contamination, which is of relevance for immunosuppressed patients. Another common additive used to nurture SCs is foetal bovine serum, and bovine serum proteins have been found to persist in human skin keratinocytes even after cultures are switched to a serum-free environment. 95 These contaminants may have consequences in relation to immunological response when cells are grafted into human hosts. 96 HAM, the innermost layer of the placenta, is a non-antigenic, antiinflammatory biocompatible matrix that has the ability to prolong the lifespan of progenitors and support multiple epithelial layers before being resorbed into the ocular surface. However, because of its foreign nature, it requires carefully screening, preparation and storage and is therefore an additional built-in risk and cost to the procedure. Fibrin glue is the other major cell support and SC carrier to diseased corneas. It is a product of pooled donor plasma and may also contain bovine protease inhibitors, thereby increasing the risk of disease transmission. 97 Finally, it should be noted that SC therapies that include peripheral blood, cord blood or bone marrow for the treatment of non-ocular disease (haematological and lymphoid malignancies) can result in the development of a range of ocular complications, such as graft-versus-host disease, cataract, dry eye, glaucoma 98 as well as ocular surface disease 99 including rare but malignant squamous cell carcinomas of the conjunctiva. 
